Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Altimmune Inc
(NQ:
ALT
)
6.550
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Altimmune Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
12 Health Care Stocks Moving In Thursday's After-Market Session
December 30, 2021
Gainers Kiora Pharmaceuticals (NASDAQ:KPRX
Via
Benzinga
Wingstop, Akamai Initiations Among Today's Top Calls On Wall Street
December 29, 2021
Benchmark analyst Todd Brooks initiated coverage of Wingstop (WING) with a Hold rating and no price target. The analyst believes the stock's risk/reward is balanced at these levels given the current
Via
Talk Markets
ALTIMMUNE INC (ALT) Q3 2021 Earnings Call Transcript
November 11, 2021
ALT earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 29, 2021
Gainers NuCana (NASDAQ:NCNA) stock increased by 22.36% to $2.9 during Wednesday's regular session. The current volume of 77.9 million shares is 21650.59% of NuCana...
Via
Benzinga
Understanding Altimmune's Unusual Options Activity
August 11, 2021
Altimmune (NASDAQ:ALT) shares experienced unusual options ...
Via
Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
Exposures
Product Safety
Analyzing Altimmune's Unusual Options Activity
August 03, 2021
On Tuesday, shares of Altimmune (NASDAQ:ALT) saw unusual o...
Via
Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (...
Via
Benzinga
Exposures
COVID-19
52 Biggest Movers From Yesterday
September 30, 2021
Gainers Paltalk, Inc. (NASDAQ: PALT) shares jumped 60.1% to close at $8.39 on Wednesday. Smart Share Global Limited (NASDAQ: EM) jumped 36.2% to close at $3.91. Smart Share...
Via
Benzinga
33 Stocks Moving In Wednesday's Mid-Day Session
September 29, 2021
Gainers Paltalk, Inc. (NASDAQ: PALT) shares climbed 37% to $7.18. NuCana plc (NASDAQ: NCNA) jumped 31.4% to $3.1150. The FDA granted Fast Track designation to NuCana’s...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 29, 2021
Gainers Geovax Labs (NASDAQ:GOVX) shares increased by 23.44% to $5.16 during Wednesday's pre-market session. The market value of their outstanding shares is at $32.6...
Via
Benzinga
H.C. Wainwright Sees Buying Opportunity In This Biotech Stock Sell Off
September 28, 2021
H.C. Wainwright said that Altimmune Inc (NASDAQ:
Via
Benzinga
ALT Stock: One Analyst Still Thinks Altimmune Prices Could Hit $34
September 28, 2021
Some clinical trial results released by Altimmune have shareholders rushing to sell. But, one analyst sees plenty of upside for ALT stock.
Via
InvestorPlace
Dow Set to Snap Win Streak as Tech Sector Weighs
September 28, 2021
The Dow Jones Industrial Average looks ready to snap its four-day win streak, as the tech sector's recent rout catches up with the index, which was last seen down 419 points.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Why Altimmune Stock Is Under Pressure Today
September 28, 2021
Safety concerns poured water on otherwise positive clinical trial results for the company's experimental weight-loss drug.
Via
The Motley Fool
See Why Altimmune Stock Plunged After Obesity Trial Data
September 28, 2021
Altimmune Inc (NASDAQ: ALT) has announced results from a 12-week, Phase 1 trial of pemvidutide (ALT-801), an investigational glucagon-like peptide-1 (GLP-1)/glucagon dual...
Via
Benzinga
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
September 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 27) Acceleron Pharma Inc. (...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 28, 2021
Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) shares increased by 70.28% to $9.11 during Tuesday's pre-market session. The company's market cap stands at $24.5...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
September 27, 2021
Gainers Paratek Pharmaceuticals (NASDAQ:PRTK...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 17, 2021
Gainers Celularity (NASDAQ:CELU) shares rose 7.0% to $7.33 during Tuesday's after-market session. The market value of their outstanding shares is at $904.9...
Via
Benzinga
ALTIMMUNE INC (ALT) Q2 2021 Earnings Call Transcript
August 11, 2021
ALT earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 11, 2021
Gainers CohBar (NASDAQ:CWBR) stock moved upwards by 68.21% to $2.17 during Wednesday's pre-market session. The company's market cap stands at $134.0 million. The...
Via
Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Monday's After-Market Session
July 19, 2021
Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO
Via
Benzinga
Cramer Gives His Opinion On AT&T, Cemex And More
July 11, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer said he is not a fan of AT&T Inc. (NYSE: T). For growth, he would go with T-Mobile Us Inc (NASDAQ: TMUS) and...
Via
Benzinga
Understanding Altimmune's Unusual Options Activity
July 08, 2021
Altimmune (NASDAQ:ALT) shares experienced unusual options activity on Thursday. The stock price moved up to $8.78 following the option alert. Sentiment: BEARISH Option Type:...
Via
Benzinga
The Week Ahead In Biotech: Focus On Chemocentryx FDA Decision And Conference Presentations In A Light Week
July 03, 2021
Biotech stocks advanced for a second week in running, with stocks reacting to pending releases for the second quarter and the first-half of the year. The week witnessed a few COVID-19 disappointments,...
Via
Talk Markets
Exposures
COVID-19
Product Safety
The Week Ahead In Biotech: Focus On Chemocentryx FDA Decision, Conference Presentations In A Light Week
July 03, 2021
Biotech stocks advanced for a second week in running, with stocks reacting to pending releases for the second quarter and the first-half of the year. The week witnessed a few...
Via
Benzinga
Exposures
Product Safety
72 Biggest Movers From Yesterday
July 01, 2021
Gainers Pop Culture Group Co., Ltd (NASDAQ: CPOP) shares jumped 405% to close at $30.30 on Wednesday after the company priced its IPO at $6 per share. Cuentas Inc. (NASDAQ: CUEN...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Why Altimmune Is Crashing Today
June 30, 2021
The company halts development on both a COVID-19 vaccine and a drug targeting the disease.
Via
The Motley Fool
Exposures
COVID-19
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.